Cargando…
Hypereosinophilic syndromes
Hypereosinophilic syndromes (HES) constitute a rare and heterogeneous group of disorders, defined as persistent and marked blood eosinophilia (> 1.5 × 10(9)/L for more than six consecutive months) associated with evidence of eosinophil-induced organ damage, where other causes of hypereosinophilia...
Autores principales: | Roufosse, Florence E, Goldman, Michel, Cogan, Elie |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2045078/ https://www.ncbi.nlm.nih.gov/pubmed/17848188 http://dx.doi.org/10.1186/1750-1172-2-37 |
Ejemplares similares
-
Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome
por: Roufosse, Florence, et al.
Publicado: (2023) -
Response to a case report: Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
por: Requena, Gema, et al.
Publicado: (2021) -
Case report: Serious unexpected vascular events in two patients with lymphocytic variant hypereosinophilic syndrome
por: Nathan, Torcida, et al.
Publicado: (2023) -
Cardiac involvement in hypereosinophilic syndrome
por: Mansour, Mohamad Jihad, et al.
Publicado: (2018) -
Literature reviews of stroke with hypereosinophilic syndrome
por: Ono, Ryohei, et al.
Publicado: (2021)